You can buy or sell Zosano Pharma and other stocks, options, and ETFs commission-free!
Zosano Pharma Corporation Common Stock, also called Zosano Pharma, is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The firm focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. It offers Qtrypta, a formulation of zolmitriptan delivered utilizing the intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. The listed name for ZSAN is Zosano Pharma Corporation Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 11, After Hours